COSTA, CINZIA
 Distribuzione geografica
Continente #
NA - Nord America 4.256
AS - Asia 3.524
EU - Europa 3.152
SA - Sud America 678
Continente sconosciuto - Info sul continente non disponibili 290
AF - Africa 110
OC - Oceania 8
Totale 12.018
Nazione #
US - Stati Uniti d'America 4.118
SG - Singapore 1.562
BR - Brasile 508
CN - Cina 504
IE - Irlanda 504
IT - Italia 502
HK - Hong Kong 499
RU - Federazione Russa 418
VN - Vietnam 382
FR - Francia 371
UA - Ucraina 314
DE - Germania 245
SE - Svezia 227
FI - Finlandia 176
GB - Regno Unito 121
KR - Corea 119
BD - Bangladesh 86
IN - India 80
CA - Canada 66
AR - Argentina 63
NL - Olanda 60
TR - Turchia 39
IQ - Iraq 36
RO - Romania 36
MX - Messico 35
JP - Giappone 30
PK - Pakistan 30
ID - Indonesia 28
PL - Polonia 28
ZA - Sudafrica 27
AT - Austria 26
BE - Belgio 22
SA - Arabia Saudita 20
CL - Cile 19
CZ - Repubblica Ceca 19
VE - Venezuela 19
CO - Colombia 18
UZ - Uzbekistan 18
LT - Lituania 17
EC - Ecuador 16
MA - Marocco 16
CH - Svizzera 15
ES - Italia 13
DZ - Algeria 12
PY - Paraguay 12
EG - Egitto 11
PH - Filippine 11
IL - Israele 9
KE - Kenya 9
LB - Libano 9
MY - Malesia 9
TN - Tunisia 9
BO - Bolivia 8
GR - Grecia 8
JM - Giamaica 8
UY - Uruguay 8
AU - Australia 7
PE - Perù 7
SC - Seychelles 7
AE - Emirati Arabi Uniti 6
ET - Etiopia 6
KZ - Kazakistan 6
PS - Palestinian Territory 6
AL - Albania 5
AZ - Azerbaigian 5
EU - Europa 5
PT - Portogallo 5
JO - Giordania 4
NI - Nicaragua 4
BB - Barbados 3
BG - Bulgaria 3
CR - Costa Rica 3
GT - Guatemala 3
KG - Kirghizistan 3
NP - Nepal 3
OM - Oman 3
RS - Serbia 3
TT - Trinidad e Tobago 3
BY - Bielorussia 2
CI - Costa d'Avorio 2
CW - ???statistics.table.value.countryCode.CW??? 2
DM - Dominica 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HU - Ungheria 2
KW - Kuwait 2
LV - Lettonia 2
MO - Macao, regione amministrativa speciale della Cina 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AD - Andorra 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
CY - Cipro 1
GA - Gabon 1
Totale 11.711
Città #
Singapore 1.120
Chandler 566
Dublin 499
Hong Kong 494
San Jose 394
Ashburn 281
Boardman 203
San Mateo 203
Santa Clara 188
Jacksonville 171
Beijing 151
Moscow 148
Altamura 137
Perugia 136
Lauterbourg 129
Seoul 119
Medford 111
Princeton 109
Dong Ket 108
Lawrence 101
Munich 91
Wilmington 86
Ann Arbor 82
Ho Chi Minh City 80
Andover 74
Los Angeles 74
Hanoi 62
The Dalles 59
Turku 58
Des Moines 52
Helsinki 48
São Paulo 48
New York 43
Redmond 43
Piscataway 41
Amsterdam 34
Frankfurt am Main 34
London 29
Orem 27
Dallas 22
Montreal 22
Rio de Janeiro 22
Tokyo 22
San Paolo di Civitate 21
Warsaw 21
Brooklyn 20
Brussels 20
Houston 20
Atlanta 19
Bucharest 19
Chicago 19
Saint Petersburg 19
Nuremberg 18
Woodbridge 18
Chennai 17
Council Bluffs 17
Norwalk 17
Denver 16
Johannesburg 16
Rome 16
Stockholm 16
Baghdad 15
Haiphong 15
Milan 14
Poplar 14
Boston 13
Brasília 13
Falkenstein 13
Florence 13
Naples 13
Toronto 13
Mexico City 11
Phoenix 11
Tashkent 11
Campinas 10
Columbus 10
Curitiba 10
Da Nang 10
Izmir 10
New Delhi 10
Riyadh 10
San Francisco 10
Tianjin 10
Falls Church 9
Istanbul 9
Jakarta 9
Redwood City 9
Asunción 8
Belo Horizonte 8
Boydton 8
Medellín 8
Santiago 8
Caracas 7
Goiânia 7
Guarulhos 7
Nairobi 7
Olomouc 7
Vienna 7
Zhengzhou 7
Ankara 6
Totale 7.240
Nome #
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit 219
A critical role of NO/cGMP/PKG dependent pathway in hippocampalpost-ischemic LTP: modulation by zonisamide. 150
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 140
Decreased NR2B Subunit Synaptic Levels Cause Impaired Long-Term Potentiation But Not Long-Term Depression 138
Brain arteriovenous malformations and seizures: an Italian study. 136
Hippocampal epileptogenesis in autoimmune encephalitis 132
c-Jun N-terminal Kinase regulates soluble Abeta oligomers and cognitive impairment in an AD mouse model. 127
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 127
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation. 125
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 125
Evaluating bexicaserin for the treatment of developmental epileptic encephalopathies 123
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. 123
A novel ATP1A2 gene mutation in familial hemiplegic migraine and epilepsy. 122
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 121
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission 121
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 120
Alectinib's activity against CNS metastases from ALK-positive non-small cell lung cancer: a single institution case series 119
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 119
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition 119
Plasticity and repair in the post-ischemic brain 118
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 115
Occipital arteriovenous malformations andmigraine. 114
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. 114
Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system 114
Epilepsy in hemiplegic migraine: Genetic mutations and clinical implications 114
Levetiracetam-associated hyponatremia. 113
Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunction. 113
An Italian multicentre study of perampanel in progressive myoclonus epilepsies 113
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine. 112
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. 112
Management of epilepsy in brain tumors 111
Cannabidiol: metabolism and clinical efficacy in epileptic patients 110
Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice 109
A 1H magnetic resonance spectroscopy study in patients with obstructive sleep apnea. 107
Differential effect of FHM2 mutation on synaptic plasticity in distinct hippocampal regions 107
Amyloid-β: a potential link between epilepsy and cognitive decline 106
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 102
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. 101
Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission. 101
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease. 100
MBOAT7 encephalopathy: Characterizing the neurology and epileptology 99
Effect of psychotropic drugs on seizure threshold 99
Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events 99
Liverpool Adverse Events Profile: Italian validation and predictive value for dropout from antiepileptic treatment in people with epilepsy 99
Mechanisms underlying altered striatal synaptic plasticity in old A53T-α synuclein overexpressing mice. 98
Sleep disorders and late-onset epilepsy of unknown origin: Understanding new trajectories to brain amyloidopathy 98
Rapid effect of levetiracetam in a case of juvenile myoclonic epilepsy 97
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment. 96
Lacosamide protects striatal and hippocampal neurons from in vitro ischemia without altering physiological synaptic plasticity 96
Neural 17beta-estradiol facilitates long-term potentiation in the hippocampal CA1 region 95
Cortical spreading depression as a target for anti-migraine agents. 94
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 94
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: Role of Na(+)/K(+) ATPase. 93
O064. Antiepileptic drugs in migraine and epilepsy disorders: who is at increased risk of adverse events? 92
The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease. 91
Effect of Brivaracetam on Efficacy and Tolerability in Patients With Brain Tumor-Related Epilepsy: A Retrospective Multicenter Study 91
Obsessive-compulsive disorder and migraine with medication-overuse headache. 90
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 89
CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma 89
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. 87
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 87
Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics 87
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 86
Clinical and Instrumental Characterization of Patients With Late-Onset Epilepsy 86
Hyperhomocysteinemia and retinal vascular changes in patients with epilepsy. 85
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. 85
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 85
Late onset epilepsy and Alzheimer's disease: exploring the dual pathogenic role of amyloid-β 84
Two-year longitudinal monitoring of amnestic mild cognitive impairment patients with prodromal Alzheimer's disease using topographical biomarkers derived from functional magnetic resonance imaging and electroencephalographic activity 84
An unbalanced synaptic transmission: Cause or consequence of the amyloid oligomers neurotoxicity? 84
Incidence and Antiseizure Medications of Post-stroke Epilepsy in Umbria: A Population-Based Study Using Healthcare Administrative Databases 84
Chronic cocaine prevents depotentiation at corticostriatal synapses. 83
Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study 82
Na+/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area. 81
A loss-of-function HCN4 mutation associated with familial benign myoclonic epilepsy in infancy causes increased neuronal excitability 80
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 80
Degradation of endocannabinoids in chronic migraine and medication overuse headache. 79
Levetiracetam in newly diagnosed late-onset post-stroke seizures: a prospective observational study. 78
Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs. 78
Environmental enrichment restores CA1 hippocampal LTP and reduces severity of seizures in epileptic mice. 78
Epm2aR240X knock-in mice present earlier cognitive decline and more epileptic activity than Epm2a-/- mice 76
Antiepileptic drugs in migraine and epilepsy: Who is at increased risk of adverse events? 76
Migraine and epilepsy: what value today? 76
Expanding the phenotype of ASXL3-related syndrome: A comprehensive description of 45 unpublished individuals with inherited and de novo pathogenic variants in ASXL3 76
Clinical features and outcome of 6 new patients carrying de novoKCNB1gene mutations 75
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences 75
Neuroprotection as a potential therapeutic perspective in neurodegenerative diseases: Focus on antiepileptic drugs 75
Cognitive Decline Risk Stratification in People with Late-Onset Epilepsy of Unknown Etiology: An Electroencephalographic Connectivity and Graph Theory Pilot Study 74
Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity. 74
Upfront pembrolizumab as an effective treatment start in patients with PD-L1 ≥ 50% non-oncogene addicted non-small cell lung cancer and asymptomatic brain metastases: an exploratory analysis 74
Corticostriatal LTP requires combined mGluR1 and mGluR5 activation. 73
Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies. 72
IRF2BPL: A new genotype for progressive myoclonus epilepsies 70
Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia. 69
Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study. 69
Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. 69
Locally Synthetized 17-β-Estradiol Reverses Amyloid-β-42-Induced Hippocampal Long-Term Potentiation Deficits 68
CalDAG-GEFI mediates striatal cholinergic modulation of dendritic excitability, synaptic plasticity and psychomotor behaviors 68
Late-onset n-acetylglutamate synthase deficiency: Report of a paradigmatic adult case presenting with headaches and review of the literature 67
Management of epilepsy in older adults: A critical review by the ILAE Task Force on Epilepsy in the elderly 66
Totale 9.796
Categoria #
all - tutte 56.571
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.571


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022886 0 168 30 42 33 13 13 262 19 54 124 128
2022/20231.831 118 377 33 150 165 195 0 67 656 8 45 17
2023/2024803 43 75 34 10 3 3 177 11 117 26 152 152
2024/20251.921 25 162 91 122 220 118 92 154 328 121 324 164
2025/20264.814 296 330 327 649 694 392 728 255 476 400 174 93
2026/2027145 95 50 0 0 0 0 0 0 0 0 0 0
Totale 12.018